Granuloma annulare arising under systemic psoriasis therapy successfully treated with adalimumab
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
JAAD case reports - 6(2020), 9 vom: 06. Sept., Seite 832-834 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fässler, Mirjam [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 28.09.2020 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.jdcr.2020.07.013 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314480129 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314480129 | ||
| 003 | DE-627 | ||
| 005 | 20231225152825.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jdcr.2020.07.013 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1048.xml |
| 035 | |a (DE-627)NLM314480129 | ||
| 035 | |a (NLM)32875031 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fässler, Mirjam |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Granuloma annulare arising under systemic psoriasis therapy successfully treated with adalimumab |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 28.09.2020 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a GA, Granuloma annulare | |
| 650 | 4 | |a IL, interleukin | |
| 650 | 4 | |a PASI, Psoriasis Area and Severity Index | |
| 650 | 4 | |a TNF, tumor necrosis factor | |
| 650 | 4 | |a Th, T helper | |
| 650 | 4 | |a Th1, T helper 1 | |
| 650 | 4 | |a adalimumab | |
| 650 | 4 | |a biologics | |
| 650 | 4 | |a granuloma annulare | |
| 650 | 4 | |a psoriasis | |
| 650 | 4 | |a secukinumab | |
| 650 | 4 | |a treatment | |
| 650 | 4 | |a tumor necrosis factor-α inhibitor | |
| 700 | 1 | |a Schlapbach, Christoph |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JAAD case reports |d 2015 |g 6(2020), 9 vom: 06. Sept., Seite 832-834 |w (DE-627)NLM255357753 |x 2352-5126 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2020 |g number:9 |g day:06 |g month:09 |g pages:832-834 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jdcr.2020.07.013 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2020 |e 9 |b 06 |c 09 |h 832-834 | ||